Peter Rahmer

Insider Reports History

Entity
Individual
Location
C/O Relay Therapeutics, Inc., 399 Binney Street, 2 Nd Floor, Cambridge, MA
Signature
/s/ Brian Adams, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Rahmer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Relay Therapeutics, Inc. Chief Corporate Development Officer Common Stock 402K $1.14M $2.84 Mar 27, 2025 Direct
Relay Therapeutics, Inc. Chief Corporate Development Officer Stock Option (Right to Buy) 275K Jan 10, 2025 Direct

Insider Reports Filed by Peter Rahmer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RLAY Relay Therapeutics, Inc. Mar 27, 2025 1 -$701 4 Mar 31, 2025 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jan 28, 2025 4 -$205K 4 Jan 30, 2025 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jan 10, 2025 1 $0 4 Jan 14, 2025 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jan 2, 2025 3 -$346K 4 Jan 6, 2025 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Dec 27, 2024 1 -$1.75K 4 Dec 31, 2024 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Oct 28, 2024 1 -$9.82K 4 Oct 30, 2024 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Sep 27, 2024 1 -$1.84K 4 Oct 1, 2024 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jul 29, 2024 4 -$353K 4 Jul 31, 2024 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jun 27, 2024 2 $10.1K 4 Jul 1, 2024 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jun 3, 2024 3 -$542K 4 Jun 5, 2024 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Apr 29, 2024 1 -$8.58K 4 Apr 29, 2024 Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Mar 27, 2024 1 -$2.29K 4 Mar 29, 2024 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jan 29, 2024 1 -$15.9K 4 Jan 31, 2024 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jan 16, 2024 1 $0 4 Jan 18, 2024 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Dec 27, 2023 1 -$2.81K 4 Dec 29, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Oct 30, 2023 1 -$8.16K 4 Nov 1, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Sep 27, 2023 2 $15.7K 4 Sep 29, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jul 28, 2023 1 -$16K 4 Jul 31, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jun 27, 2023 1 -$2.96K 4 Jun 28, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. May 30, 2023 1 $0 4 Jun 1, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Apr 28, 2023 1 -$18.5K 4/A Jun 1, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Mar 27, 2023 1 -$4.56K 4 Mar 28, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jan 30, 2023 1 -$16K 4 Jan 31, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Jan 17, 2023 3 $0 4 Jan 19, 2023 Title: Chief Corporate Development Officer
RLAY Relay Therapeutics, Inc. Dec 31, 2022 0 $0 3 Jan 5, 2023 Title: Chief Corporate Development Officer